Skip to content
Screener

CorMedix CRMD Price / book

Price / book at other companies

Pfizer logo
PfizerPFE
1.8×+0.2×
Merck & Co. logo
Merck & Co.MRK
7.6×+3.5×
Merit Medical Systems logo
Merit Medical SystemsMMSI
2.5×-1.8×
IAR
Integra LifeSciencesIART
1.3×+0.5×
ICU Medical logo
ICU MedicalICUI
1.7×+0.2×
TFX
TeleflexTFX
1.9×+0.7×

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$583.68M-22.4%
P/E3.2×
P/S1.5×-4.7×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

Based on the most recent quarter.

The source filing: CorMedix’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 8:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001410098-26-000021

FAQ

What is CorMedix's price / book?
CorMedix (CRMD) reported price / book of 1.2× in Q1 2026.
How has CorMedix's price / book changed year-over-year?
CorMedix's price / book decreased by 64.9% year-over-year, from 3.5× to 1.2×.
What is the long-term trend for CorMedix's price / book?
Over 5 years (2020 to 2025), CorMedix's price / book has grown at a -18.8% compound annual growth rate (CAGR), from 6.4× to 2.3×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about CorMedix's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude